<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhu T</submitter><funding>Major Science and Technology Projects in Yunnan Province</funding><pagination>867525</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9081565</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13</volume><pubmed_abstract>This study aimed to elucidate the mechanism of &lt;i>Bletilla striata&lt;/i> oligosaccharides (BO) in the treatment of ulcerative colitis (UC). A UC mouse model was induced by 3% Dextran sodium sulfate (DSS), and BO (200 mg/kg/d) were administered for intervention. The results show that BO effectively inhibited the release of intestinal inflammatory cytokines such as IL-6, TNF-α, and IL-1β. Also, BO profoundly elevated the secretion of mucins and the expression of tight junction (TJ) proteins to attenuate dysfunction of the intestinal barrier. The 16S rDNA sequencing and liquid chromatography/gas chromatography-mass spectrometer (LC/GC-MS) analysis of mouse feces revealed that BO regulated the disturbance of gut microbiota and intestinal metabolites. By using the &lt;i>in vitro&lt;/i> fermentation bro</pubmed_abstract><journal>Frontiers in pharmacology</journal><pubmed_title>&lt;i>Bletilla striata&lt;/i> Oligosaccharides Improve Ulcerative Colitis by Regulating Gut Microbiota and Intestinal Metabolites in Dextran Sulfate Sodium-Induced Mice.</pubmed_title><pmcid>PMC9081565</pmcid><funding_grant_id>202102AE090042</funding_grant_id><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Ye C</pubmed_authors><pubmed_authors>Hu H</pubmed_authors><pubmed_authors>Yin M</pubmed_authors><pubmed_authors>Hu B</pubmed_authors><pubmed_authors>Zhu T</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>Bletilla striata&lt;/i> Oligosaccharides Improve Ulcerative Colitis by Regulating Gut Microbiota and Intestinal Metabolites in Dextran Sulfate Sodium-Induced Mice.</name><description>This study aimed to elucidate the mechanism of &lt;i>Bletilla striata&lt;/i> oligosaccharides (BO) in the treatment of ulcerative colitis (UC). A UC mouse model was induced by 3% Dextran sodium sulfate (DSS), and BO (200 mg/kg/d) were administered for intervention. The results show that BO effectively inhibited the release of intestinal inflammatory cytokines such as IL-6, TNF-α, and IL-1β. Also, BO profoundly elevated the secretion of mucins and the expression of tight junction (TJ) proteins to attenuate dysfunction of the intestinal barrier. The 16S rDNA sequencing and liquid chromatography/gas chromatography-mass spectrometer (LC/GC-MS) analysis of mouse feces revealed that BO regulated the disturbance of gut microbiota and intestinal metabolites. By using the &lt;i>in vitro&lt;/i> fermentation bro</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-05T13:23:35.74Z</modification><creation>2025-02-19T03:27:28.018Z</creation></dates><accession>S-EPMC9081565</accession><cross_references><pubmed>35548331</pubmed><doi>10.3389/fphar.2022.867525</doi></cross_references></HashMap>